VICTORY CAPITAL MANAGEMENT INC - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 208 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$144,489
+1.6%
20,408
+1.0%
0.00%
Q2 2023$142,271
-17.5%
20,209
-2.3%
0.00%
Q1 2023$172,455
-99.4%
20,678
-99.2%
0.00%
-100.0%
Q4 2022$29,085,544
-34.4%
2,533,584
-28.0%
0.03%
-36.5%
Q3 2022$44,355,000
-8.2%
3,520,231
-22.9%
0.05%
-5.5%
Q2 2022$48,297,000
-16.1%
4,564,930
+28.5%
0.06%
-5.2%
Q1 2022$57,538,000
+841.4%
3,553,521
+705.3%
0.06%
+866.7%
Q4 2021$6,112,000
-8.4%
441,266
-4.9%
0.01%
-14.3%
Q3 2021$6,670,000
-35.5%
464,174
-29.0%
0.01%
-30.0%
Q2 2021$10,337,000
+48.3%
653,829
-4.6%
0.01%
+42.9%
Q1 2021$6,971,000
+1.0%
685,484
-26.0%
0.01%
-12.5%
Q4 2020$6,904,000
+67.8%
926,679
-22.6%
0.01%
+60.0%
Q3 2020$4,114,000
+197.7%
1,197,555
+313.0%
0.01%
+150.0%
Q2 2020$1,382,000
+1282.0%
289,964
+484.2%
0.00%
Q1 2020$100,000
+100.0%
49,638
+187.2%
0.00%
Q3 2019$50,00017,2810.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
DG Capital Management, LLC 1,186,726$4,076,0002.45%
Sarissa Capital Management LP 4,861,000$16,697,0001.97%
Ghost Tree Capital, LLC 1,950,000$6,698,0001.94%
ORACLE INVESTMENT MANAGEMENT INC 2,525,857$8,676,0001.14%
Eversept Partners, LP 1,143,211$3,926,9300.87%
DAFNA Capital Management LLC 749,051$2,573,0000.84%
KNOTT DAVID M 397,361$1,365,0000.80%
Parkman Healthcare Partners LLC 800,740$2,751,0000.73%
ACUTA CAPITAL PARTNERS, LLC 660,000$2,267,0000.62%
Formidable Asset Management, LLC 578,200$1,949,0000.57%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders